New obesity pill combo enters first human safety trial
Disease control
Recruiting now
This early-stage study tests whether a new oral drug, VRB-103, is safe and tolerable when taken alone or with another drug (ecnoglutide) in people with obesity or overweight. About 336 participants will receive either the drug or a placebo. The goal is to check for side effects, …
Phase: PHASE1 • Sponsor: Verdiva Bio Dev Limited • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC